drugset / Trial / NCT06082232

Adjuvants With Intrathecal Bupivacaine for Postoperative Analgesia

NCT06082232 ↗

Phase 4 Unknown 90 enrolled Assiut University
RandomizedFactorialDouble-blindPrevention

Summary

The aim of this study is to compare the postoperative analgesic effect of intrathecal dexmedetomidine combined with bupivacaine and midazolam combined with bupivacaine in high tibial osteotomy.

Timeline

Start
2023-11-01
Primary completion
2024-11-01
Completion
2024-12-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexmedetomidine Other / unclassified 5 ug Intrathecal
Comparator Midazolam Small molecule 1 mg Intrathecal
Comparator Bupivacaine Other / unclassified 20 mg Intrathecal

Indications

No indication recorded.